NL-OMON54286招募中4 期
Prediction of Response Of horMOnal Treatment in advanced and recurrent Endometrial cancer - PROMOTE study
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Advanced stage (FIGO stage III and IV) and recurrent endometrial cancer
- •All histologic types of endometrial carcinoma
- •Planned treatment with any type of hormonal therapy
- •Biopsy taken within 120 days prior to start of hormonal therapy with no
- •intercurrent therapy between biopsy and start of hormonal therapy
- •In metastatic EC, histological sampling of one distant metastasis is
- •recommended
排除标准
- •Adjuvant hormonal therapy immediately started after surgery
- •Synchronous use of hormonal therapy for other indications
- •Endometrial sarcoma or endometrial stroma cell sarcoma
研究者
相似试验
招募中
不适用
Comparison between different doses of gonadotropin-releasing hormone agonist used in short stimulation protocol in infertile women undergoing IVFReproductive Health and Childbirth - Fertility including in vitro fertilisationInfertilityACTRN12613000384752Sarhan IVF Cntre90
进行中（未招募）
不适用
MIrena coil to Reduce Endometrial Neoplastic AbnormalitiesEndometrial hyperplasia and endometrioid adenocarcinoma of the endometriumCancerISRCTN31662931Central Manchester University Hospitals NHS Trust (CMFT) (UK)150
招募中
4 期
Early mental response to hormonal treatment in transgender men - The EMRE Study2024-517052-35-00Karolinska University Hospital70
已完成
2 期
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermianon-obstructive azoospermia.Male infertilityIRCT201612069014N137Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences28
进行中（未招募）
不适用
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI